PTC Therapeutics reported $-206546000 in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 822.38M 57.14M Jun/2025
Alnylam Pharmaceuticals USD 250.59M 135.16M Jun/2025
Amgen USD 7.43B 1.22B Jun/2025
Biogen USD 17.63B 655.3M Jun/2025
BioMarin Pharmaceutical USD 6.03B 233.65M Jun/2025
Cytokinetics USD -737440000 471.03M Jun/2025
Daiichi Sankyo JPY 1.58T 44.86B Jun/2025
Gilead Sciences USD 19.67B 596M Jun/2025
Incyte USD 4.17B 503.34M Jun/2025
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
Ironwood Pharmaceuticals USD -301245000 10.09M Dec/2024
Novartis USD 42.05B 3.6B Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
PTC Therapeutics USD -206546000 20.79M Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Sarepta Therapeutics USD 1.36B 214.66M Jun/2025
TG Therapeutics USD 276.43M 39.14M Jun/2025
Ultragenyx Pharmaceutical USD 151.29M 7.04M Jun/2025
Vertex Pharmaceuticals USD 17.18B 679.1M Jun/2025
Xencor USD 620.35M 19.52M Jun/2025